Helping more Black and Latino patients join cancer trials
Part of Cancer clinical trials.
This study tests a new program to make it easier for Black and Latino people with cancer to join clinical trials. Your participation can help researchers learn how to improve access for everyone.
Summary written for real people, not researchers, by Clin2.
Who can take part
- You must be 18 years old or older.
- You must identify as Black and/or Latino.
- You must be a cancer patient at a participating community oncology clinic.
- You must be eligible for another ECOG-ACRIN cancer trial.
- You must be able to understand and sign an electronic consent form.
- You must speak English or Spanish and have access to a phone or device.
Quick eligibility check
Answer a few plain-language questions, based on this study's own requirements, to get a preliminary sense of fit.
Similar studies
Other trials that look related to this one.
This study tests an approach to help people from groups historically underrepresented in cancer trials learn about and connect to clinical trials. It may help you get easier, more personal ways to be contacted about research options.
This study looks at how doctors and patients talk about clinical trials, with the goal of improving conversations for everyone involved. If you join, you'll fill out questionnaires about your experiences.
This trial offers support and resources to help people who had a suspicious cancer screening result or were referred to a special diagnostic clinic. It is designed for African American, Hispanic, or people living in high-need zip code areas.
This study tests new ways to connect people in Florida communities with cancer care and research opportunities. It focuses on making it easier for patients, doctors, and community members to learn about and join clinical trials.
This trial tests a support program designed to help Latino and Hispanic young adults cope with the challenges of cancer. It focuses on reducing distress and helping you move toward your goals.
This trial is testing a new way to use genetic testing (Gene PilotLX) for Latinx patients with solid tumor cancers. It aims to see if this approach can help personalize cancer care for the Latinx community.
Hear when a new Cancer trial opens
We’ll email you when one opens — at most once a week, no account needed, unsubscribe anytime.